Insider Trading News

Accenture’s chair and CEO sells shares price $885,142

Julie Spellman Candy, Chair and CEO of Accenture plc (NYSE:ACN), a $220 billion market cap IT providers big with a…

1 month ago

Invizyne applied sciences CEO Michael Heltzen buys $20,345 in inventory

Michael Heltzen, the Chief Government Officer of Invizyne Applied sciences Inc. (NASDAQ:IZTC), a $100 million market cap firm, not too…

1 month ago

374Water Inc.’s Yaacov Nagar sells $69,648 in inventory

Yaacov Nagar, a major shareholder of 374Water Inc. (NASDAQ:SCWO), reported promoting a complete of 115,298 shares of the corporate's widespread…

1 month ago

Grindr GC and head of worldwide affairs sells $50,151 in inventory

Zachary Katz, Grindr Inc.'s (NYSE:GRND) Normal Counsel and Head of International Affairs, just lately offered a portion of his holdings…

1 month ago

rXsight director Corley Jesse Anderson acquires $100,004 in shares

RxSight, based mostly in Aliso Viejo, California, focuses on ophthalmic items and continues to be an lively participant within the…

1 month ago

Mersana Therapeutics chief improvement officer sells shares price $3,444

Bala Mohan, the Senior Vice President and Chief Growth Officer at Mersana Therapeutics, Inc. (NASDAQ:MRSN), not too long ago offered…

1 month ago

Mersana Therapeutics SVP sells $2,955 in inventory

Alejandra Carvajal, the Senior Vice President and Chief Authorized Officer at Mersana Therapeutics, Inc. (NASDAQ:MRSN), lately offered shares of the…

1 month ago

Mersana Therapeutics’ SVP sells shares value $4,912

CAMBRIDGE, MA—Mersana Therapeutics, Inc. (NASDAQ:MRSN), a biotech firm with a market capitalization of $76.22 million, just lately disclosed a collection…

1 month ago

Mersana Therapeutics CEO sells $2,618 in inventory

CAMBRIDGE, MA—Mersana Therapeutics, Inc. (NASDAQ:MRSN), at the moment buying and selling close to its 52-week low of $0.56, lately disclosed…

1 month ago

Mersana Therapeutics officer Timothy Lowinger sells $4,667 in inventory

In latest transactions disclosed by Mersana Therapeutics, Inc. (NASDAQ:MRSN), Timothy B. Lowinger, the corporate's Senior Vice President and Chief Science…

1 month ago